This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

All set for The EMBO Meeting 2013

September 9th, 2013

With only two weeks to go and almost a thousand participants registered, the preparations for The EMBO Meeting 2013 have reached their final stages. This year's conference takes place in Amsterdam from 21-24 September.

Kai Simons will deliver the opening keynote lecture and explain how intricate changes in membrane structure can influence how cells work. In further keynote lectures, Hans Clevers will discuss how stem cells are involved in self-renewal and disease and Sir Michael Stratton will talk about how genetic changes contribute to cancer in humans. Peter Hegemann and Georg Nagel will discuss optogenetics.

PRESS EVENTS

The Future of Cancer Genomics, Monday 23 September at 11-12 am

Press panel with Sir Michael Stratton, Thijn Brummelkamp and Kári Stefánsson. The panelists will speak and answer questions from the press on research underway to help diagnose, treat and prevent cancer. Topics include the cancer genome, diagnostics, genetic risk factors for cancer and genetic variation.

Meet the Press with Anne Glover, Monday 23 September at 6 pm

Anne Glover, Chief Scientific Adviser to the President of the European Commission, will speak and answer questions from the press about the roles of scientists, the media, and the European Commission in making the work of scientists more accessible to society. She will also talk about some challenging areas where communication needs to be improved.

Scientific programme highlights include:

More information:
www.the-embo-meeting.org/

Provided by European Molecular Biology Organization

Citation: All set for The EMBO Meeting 2013 (2013, September 9) retrieved 29 July 2026 from https://sciencex.com/wire-news/140180888/all-set-for-the-embo-meeting-2013.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.